Search clinical trials for: MB12066

Total 4 results

Yungjin Pharm. Co., Ltd.

Completed

Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Male Volunteers

Metabolic Syndrome

Korea, Republic of
Yungjin Pharm. Co., Ltd.
KT&G Corporation

Completed

Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers

Obesity | Metabolic Syndrome
Yungjin Pharm. Co., Ltd.
KT&G Corporation

Completed

Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers

Obesity | Metabolic Syndrome

Korea, Republic of
Yungjin Pharm. Co., Ltd.

Terminated

Therapeutic Exploratory Phase 2 Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoholic Fatty Liver Disease(NAFLD) Except Cirrhosis

Nonalcoholic Fatty Liver Disease

Korea, Republic of

3

Subscribe